FindTrial
Sign In

Correlation between the expression of CFIm25 in peripheral blood mononuclear cells and coronary atherosclerosis

Correlation between the expression of CFIm25 in peripheral blood mononuclear cells and coronary atherosclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061732
Enrollment
Unknown
Registered
2022-07-01
Start date
2022-07-15
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis

Interventions

Gold Standard:Coronary angiography
Index test:Expression&#32
of&#32
CFIm25&#32
in&#32
peripheral&#32
blood&#32
mononuclear&#32
cells

Sponsors

The Second Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Coronary angiography or coronary CTA examination was performed to confirm coronary atherosclerosis; 2. Routine drug therapy for coronary atherosclerosis after admission (statins, clopidogrel, aspirin, low molecular weight heparin, etc.).

Exclusion criteria

Exclusion criteria: 1. Received percutaneous coronary intervention or coronary artery bypass grafting in the past; 2. Combined with coronary myocardial bridge and congenital coronary anomaly; 3. Complicated with acute myocardial infarction; 4. Combined with valvular heart disease; 5. Combined with major underlying diseases: blood system diseases , tumor, autoimmune disease, severe hepatic insufficiency (Child-PughB, C), severe renal insufficiency (CKD3, 4, 5), systemic immune disease, heart failure, cerebral hemorrhage.

Design outcomes

Primary

MeasureTime frame
Coronary angiography;—

Countries

China

Contacts

Public ContactMei Hong
meihong@njmu.edu.cn+86 18951762896

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026